Company intelligence
GenoSafe
Your bioanalytical CRO partner for Gene and Cell Therapies
About GenoSafe
GenoSafe is a CRO providing analytical testing services for the evaluation of quality, safety and efficacy of Gene and Cell therapy candidates including : - GLP biodistribution, shedding and immunogenicity studies ; - QC testing, such as viral titration, safety and potency/efficacy testing ; - GCP bioanalysis of patient samples, including immunogenicity, shedding and gene expression studies. GenoSafe brings more than 15 years of experience in the development, qualification and validation of key analytical methods for product and sample testing.
Verified activity
Signals from GenoSafe
2 published signals
Presence & Recognition
GenoSafe is attending several key events across Europe and Asia, including Advanced Therapies Europe in Spain, EUROTOX 2026 in Austria, and Mission entreprise in South Korea.
Reported by GenoSafe
Research & Knowledge
GenoSafe colleagues Laurence Jeanson-Leh and Sabrina Triffault made a point on a recent Cell & Gene panel with Viralgen and Darkhorse regarding characterisation methods for a novel capsid.
Reported by Alain Lamproye